Atlas Capital Advisors LLC Iovance Biotherapeutics, Inc. Transaction History

Atlas Capital Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	BUY	$9.53 - $13.11 $9,053 - $12,454	950 New	950 $9.1 Million
Q2 2022 Aug 16, 2022	SELL	$6.38 - $18.33 $6,061 - $17,413	-950 Closed	0 $0
Q2 2021 Jul 30, 2021	BUY	$16.33 - $33.07 $4,898 - $9,921	300 Added 46.15%	950 $24,000
Q4 2020 Feb 16, 2021	BUY	$28.04 - $50.26 $18,226 - $32,669	650 New	650 $30,000
Q3 2020 Oct 23, 2020	SELL	$27.75 - $36.3 $18,037 - $23,594	-650 Closed	0 $0
Q2 2020 Jul 28, 2020	BUY	$27.21 - $41.0 $17,686 - $26,650	650 New	650 $17,000

316

244M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $898M
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Atlas Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Atlas Capital Advisors LLC with notifications on news.